Julia Martínez Gómez

8PUBLICATIONS
119CO-AUTHORS
Molecular targetsTumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Oct 08, 2025
B cell extracellular vesicles influence melanoma response to immune checkpoint therapy.

Ala'a Al Hrout, Agshin Balayev, Karla Cervantes-Gracia

|Jan 28, 2025
Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Dec 23, 2024
Temporal genomic analysis of homogeneous tumor models reveals key regulators of immune evasion in melanoma.

Sapir Cohen Shvefel, Joy A Pai, Yingying Cao

|Mar 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Ramon Staeger, Julia M Martínez-Gómez, Patrick Turko

|Oct 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Nina Zila, Ossia M Eichhoff, Irene Steiner

Pageof 2

Frequent Collaborators

8 joint publications

Mitchell P Levesque

3 joint publications

Reinhard Dummer

2 joint publications

Sapir Cohen Shvefel

2 joint publications

Lipika R Pal